Порівняння методів

	Пілотний A/B-тест	Пілотне рандомізоване контрольоване дослідження
Галузь	Планування експерименту	Планування експерименту
Родина	Process / pipeline	Process / pipeline
Рік появи	2000s–2010s (formalized in digital experimentation literature)	1990s–2000s (methodological formalization)
Автор методу	Derived from pilot study methodology (Kraemer et al., 2006) applied to A/B testing practice	Formalized through clinical trials methodology community
Тип	Experimental design — feasibility study	Experimental feasibility design
Основоположне джерело	Thabane, L., Ma, J., Chu, R., Cheng, J., Ismaila, A., Rios, L. P., Robson, R., Thabane, M., Giangregorio, L., & Goldsmith, C. H. (2010). A tutorial on pilot studies: The what, why and how. BMC Medical Research Methodology, 10(1), 1.	Thabane, L., Ma, J., Chu, R., Cheng, J., Ismaila, A., Rios, L. P., ... & Goldsmith, C. H. (2010). A tutorial on pilot studies: the what, why and how. BMC Medical Research Methodology, 10(1), 1.
Інші назви	pilot split test, feasibility A/B test, preliminary A/B experiment, pilot randomized comparison	pilot RCT, feasibility RCT, pilot trial, preliminary RCT
Пов'язані	5	5
Підсумок	A Pilot A/B test is a small-scale, preliminary split-test experiment run before a full A/B test to assess feasibility, estimate effect sizes, detect operational problems, and validate measurement instruments. Participants are randomly assigned to a control condition (A) and a treatment condition (B), but the study is explicitly underpowered — its purpose is to inform the design of the definitive test, not to yield a conclusive comparison.	A pilot randomized controlled trial (pilot RCT) is a small-scale, fully randomized experiment conducted before a definitive RCT to test the feasibility of study procedures, estimate key parameters such as recruitment rates and effect-size variability, and identify practical barriers. It uses the same randomization, intervention, and measurement protocol as the planned full trial but on a fraction of the target sample. The goal is not to confirm efficacy but to refine and justify the main trial design.